ADMA Biologics

ADMA Biologics is an end-to-end biopharmaceutical company with three FDA-licensed approved products including ASCENIVル (Immune Globulin Intravenous – slra, Human), BIVIGAMᆴ (Immune Globulin Intravenous, Human), and NABI-HBᆴ (hepatitis B immune globulin, human).

Year Established: 2004 Stock Ticker: ADMA Exchange: NASDAQ

Locations